CN114621962B - Peanut AhBI-1 gene VIGS silencing system - Google Patents
Peanut AhBI-1 gene VIGS silencing system Download PDFInfo
- Publication number
- CN114621962B CN114621962B CN202210280701.XA CN202210280701A CN114621962B CN 114621962 B CN114621962 B CN 114621962B CN 202210280701 A CN202210280701 A CN 202210280701A CN 114621962 B CN114621962 B CN 114621962B
- Authority
- CN
- China
- Prior art keywords
- peanut
- gene
- ahbi
- silencing
- vigs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000020232 peanut Nutrition 0.000 title claims abstract description 69
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 64
- 235000017060 Arachis glabrata Nutrition 0.000 title claims abstract description 63
- 235000010777 Arachis hypogaea Nutrition 0.000 title claims abstract description 63
- 235000018262 Arachis monticola Nutrition 0.000 title claims abstract description 63
- 230000030279 gene silencing Effects 0.000 title claims abstract description 33
- 241001553178 Arachis glabrata Species 0.000 title claims abstract 15
- 230000028604 virus induced gene silencing Effects 0.000 title claims abstract 9
- 239000012634 fragment Substances 0.000 claims abstract description 22
- 239000013598 vector Substances 0.000 claims abstract description 14
- 239000013603 viral vector Substances 0.000 claims description 8
- 238000010276 construction Methods 0.000 claims description 4
- 230000003612 virological effect Effects 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 13
- 241000589158 Agrobacterium Species 0.000 abstract description 8
- 241000700605 Viruses Species 0.000 abstract description 8
- 230000014509 gene expression Effects 0.000 abstract description 8
- 239000013612 plasmid Substances 0.000 abstract description 8
- 238000011160 research Methods 0.000 abstract description 6
- 230000001404 mediated effect Effects 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 3
- 239000013604 expression vector Substances 0.000 abstract description 3
- 238000013459 approach Methods 0.000 abstract description 2
- 230000004907 flux Effects 0.000 abstract description 2
- 244000105624 Arachis hypogaea Species 0.000 description 56
- 239000007788 liquid Substances 0.000 description 27
- 241000196324 Embryophyta Species 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 14
- 230000001580 bacterial effect Effects 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 230000009466 transformation Effects 0.000 description 9
- 238000012258 culturing Methods 0.000 description 7
- 238000002156 mixing Methods 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 238000011529 RT qPCR Methods 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 238000012226 gene silencing method Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000004570 mortar (masonry) Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000007664 blowing Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 2
- 108091092584 GDNA Proteins 0.000 description 2
- 206010061217 Infestation Diseases 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 240000000220 Panda oleosa Species 0.000 description 2
- 235000016496 Panda oleosa Nutrition 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000003782 apoptosis assay Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000005522 programmed cell death Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 235000010633 broth Nutrition 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Botany (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a gene specific fragment for silencing peanut AhBI-1 gene, and constructs a corresponding VIGS virus vector and a VIGS silencing system. According to the invention, the pTRV2 virus silencing expression vector plasmid containing AhBI-1 gene specific fragments is constructed, and the peanut is transformed by an agrobacterium-mediated method, so that the endogenous AhBI-1 gene of the peanut is induced to silence, the expression level of the AhBI-1 gene of the peanut is effectively reduced, and the peanut is enabled to generate a dwarf phenotype. The inventor infects peanuts through a VIGS silencing technology, establishes a system for identifying gene functions by silencing peanut endogenous genes by pTRV-VIGS, has the advantages of rapidness, high flux and easiness in operation, and provides a new approach and technical support for developing peanut gene function research.
Description
Technical Field
The invention belongs to the technical field of plant genetic engineering, and particularly relates to a peanut AhBI-1 gene VIGS silencing system.
Background
Virus induced silencing GENE SILENCING (VIGS) refers to that after a plant is infected by a virus carrying a target gene fragment, mRNA of a specific induction sequence homologous gene is degraded or is modified by methylation and the like along with replication and transcription of the virus, so that endogenous gene silencing of the plant is caused, phenotype or physiological index change is caused, and then the function of the target gene is researched according to the phenotype variation. VIGS is a gene transcription technology developed based on plant defense mechanisms against RNA viruses to characterize plant gene function, whose inherent molecular basis may be post-transcriptional gene silencing (post-TRANSCRIPT GENE SILENCE). Compared with the traditional gene function analysis method, the VIGS can silence and analyze the function of the target gene in the current generation of infected plants; there is no need to develop stable transformants and there is the potential to silence single or multiple gene family members.
Peanut is one of five oil crops in the world, is an economic crop for eating and pressing oil, is a source of vegetable fat and protein required by people living, and plays an important role in world agricultural production and trade. Asia is the most important peanut planting area, the planting area accounts for 63.4% of the total world area, and China is the peanut producing country only in india. However, in the current production work, the technical means for peanut genomics function research are very limited, and the method for obtaining the transgenic material is rare and difficult to succeed. The agrobacterium transformation method is the most commonly used method in the current plant genetic engineering research, and has the advantages of low cost, low copy number of the introduced genes and the like. Peanut belongs to dicotyledonous plants, is one of natural hosts of agrobacterium and is self-pollinated, and although genetic transformation of peanut has been advanced in recent years, the currently constructed genetic transformation system of peanut has the problems of long transformation period, low transformation efficiency and the like, so that an efficient and rapid genetic transformation method is an important technological breakthrough for researching the gene function of peanut.
It has been reported and previously studied that the peanut AhBI-1 gene (the full-length nucleotide sequence is shown in a sequence table SEQ.ID.NO. 1) is related to programmed cell death of peanuts and is a regulatory gene for inhibiting programmed cell death of peanuts.
Disclosure of Invention
The invention aims to provide a peanut AhBI-1 gene VIGS silencing system which provides technical support for peanut functional genomics research.
In order to solve the technical problems, the invention adopts the following technical scheme:
The gene specific fragment for silencing the peanut AhBI-1 gene is AhBI-1vigs, and has a base sequence of a sequence table SEQ.ID.NO. 2.
The VIGS virus vector for silencing peanut AhBI-1 gene is pTRV2 vector containing the specific fragment of the gene.
The VIGS viral vector for silencing the peanut AhBI-1 gene is a recombinant viral vector pTRV2-AhBI-1VIGS, and is constructed by connecting the gene specific fragment to a VIGS viral backbone vector pTRV 2.
Peanut AhBI-1 gene VIGS silencing system comprising the above gene-specific fragment and VIGS viral vector.
The construction method of the peanut AhBI-1 gene VIGS silencing system mainly comprises the following steps:
Construction of the vector (I)
(II) Agrobacterium transformation
And (III) infecting peanut materials.
The step (I) is carried out according to the following steps:
(1) Amplifying AhBI-1 gene full-length sequence from peanut cDNA, and amplifying specific fragment AhBI-1vigs from AhBI-1 gene full-length sequence;
(2) Extracting pTRV2 plasmid, selecting BamHI and EcoRI enzyme cutting sites, double enzyme cutting carrier plasmid, and connecting target fragment and linearized pTRV2 carrier by using homologous recombination method;
(3) E.coli DH5 alpha is transformed, and monoclonal colony is selected for bacterial liquid PCR identification to be positive.
Step (II) is carried out according to the following steps: transforming the constructed pTRV2-AhBI-1vigs recombinant plasmid into Agrobacterium GV3101 competent cells by a freeze thawing method; then inoculating to LB solid culture medium with corresponding resistance, picking monoclonal colony, and PCR identification positive.
Step (III) is carried out according to the following steps: mixing pTRV2, pTRV2-AhBI-1vigs and pTRV2-AHPDSVIGS resuspended bacteria liquid with PTRV resuspended bacteria liquid gently in equal volume, and incubating at room temperature for 3-5h; when the third true leaf of the peanut seed just appears, carrying out infection work, injecting pre-cultured peanut lower epidermis leaf, wherein the infection area is at least more than 75% of the leaf area; dark culturing for 36-48h, normal light culturing, observing plant leaf phenotype change, and detecting expression of AhBI-1 by taking new leaves at the moment when yellow She Xianxiang with different degrees appears in positive comparison of about two weeks, namely constructing a peanut AhBI-1 gene silencing system.
The application of the gene specific fragment, the VIGS virus vector and the VIGS silencing system in silencing peanut AhBI-1 genes.
Based on previous studies, the inventors designed a gene-specific fragment for silencing the peanut AhBI-1 gene and constructed a corresponding VIGS viral vector and VIGS silencing system. According to the invention, the pTRV2 virus silencing expression vector plasmid containing AhBI-1 gene specific fragments is constructed, and the peanut is transformed by an agrobacterium-mediated method, so that the endogenous AhBI-1 gene of the peanut is induced to silence, the expression level of the AhBI-1 gene of the peanut is effectively reduced, and the peanut is enabled to generate a dwarf phenotype. The inventor infects peanuts through a VIGS silencing technology, establishes a system for identifying gene functions by silencing peanut endogenous genes by pTRV-VIGS, has the advantages of rapidness, high flux and easiness in operation, and provides a new approach and technical support for developing peanut gene function research.
Drawings
FIG. 1 is a diagram showing electrophoresis results of AhBI-1 gene amplification, in which: marker is 2000bp, and 1 and 2 are all target fragments amplified from peanut root tip cDNA.
FIG. 2 is a schematic representation of Agrobacterium-mediated pollen tube channel method transformation of peanuts, wherein: a, injecting and selecting the lower epidermis of peanut leaves; b, performing contact injection by using a 1mL injector without a needle tube; c peanut hypodermis infestation of the leaf after injection.
Figure 3 is a graph of peanut growth phenotype observations two weeks after VIGS infestation, in which: CK is wild type of Zhonghua No. 2, ahPDS positive is peanut positive control pTRV2-AHPDSVIGS, yellow leaf phenotype appears, ahBI-1 is peanut pTRV2-AhBI-1vigs plant.
Fig. 4 is a phenotypic view of peanut at sampling test, in which: WT is wild type in Zhonghua No. 2, pTRV 2-empty vector is a plant which does not contain target gene and only transfers pTRV2 empty vector into peanut, pTRV2-AHPDSVIGS is positive control plant of peanut silencing AhPDS gene, pTRV2-AhBI-1vigs is experimental plant of peanut silencing AhBI-1.
FIG. 5 is a graph showing the results of gene expression level detection of AhBI-1: CK is normal culture of Zhonghua No. 2, pTRV 2-empty vector is a plant which does not contain target gene and only transfers pTRV2 empty vector into peanut, and 1-24 is AhBI-1 infected peanut. Expression significance at test level 0.05, abc represents a significance analysis
Detailed Description
In the following examples: if not specified, the implementation methods are all conventional methods; the materials used are all purchased from conventional biochemical reagent stores; in the embodiment, the mass percentages are all unless otherwise specified; wherein the quantitative test is carried out by setting three times of repeated experiments, and the results are averaged. The primers involved in the experiments are shown in Table 1:
TABLE 1 primer list
EXAMPLE 1 obtaining of Positive bacterial liquid
1. Extraction of peanut root tip/leaf RNA
The RNA extraction method is described with reference to the general RNA extraction kit instructions of Promega (Shanghai) biological products Co., ltd. The operation steps are as follows:
(1) Preparing special gun heads and centrifuge tubes, mortar rod, medicine spoon and other devices, and sterilizing at 200 deg.c for 4 hr.
(2) Before using the mortar, precooling the sample by using liquid nitrogen, placing about 0.2g of the sample into the precooled mortar, adding enough liquid nitrogen, lightly squeezing the sample by using a mortar rod, quickly grinding the sample to be fine powder when a small amount of liquid nitrogen remains, and repeating the steps for 1-2 times (the liquid nitrogen is not volatilized to prevent RNA degradation when the sample is ground).
(3) Transferring the ground sample powder into a precooled centrifuge tube, adding 500 mu L of lysate, blowing and mixing uniformly, adding 500 mu L of diluent, blowing and mixing uniformly, and standing for 5min at room temperature.
(4) Centrifuging at 12,000rpm for 5min, sucking the supernatant, transferring to a new 1.5mL centrifuge tube, adding 500 μl of absolute ethanol, blowing, and mixing; the mixture was subjected to centrifugation at 12,000rpm for 45sec (the mixture was subjected to column chromatography several times when the sample amount was large).
(5) 600. Mu.L of the eluate was added thereto, and the mixture was centrifuged at 12,000rpm and 4℃for 45sec.
(6) Mu.L of incubation (nuclease free water: 40. Mu.L, DNase I: 5. Mu.L, 10 XDNase I buffer: 5. Mu.L) was added and incubated at room temperature for 15min.
(7) 600. Mu.L of the eluate was added thereto, and the mixture was centrifuged at 12,000rpm and 4℃for 45sec.
(8) The elution was repeated once and idling was carried out for 2min.
(9) The column was relocated to a new elution tube, 40. Mu.L of nuclease-free water was added, and the mixture was allowed to stand at room temperature for 2min at 12,000rpm and centrifuged for 1min.
(10) The eluate was again added to the column and eluted once, and the concentration was measured.
2. CDNA Synthesis
According to Northenan Biotech Co LtdIII RT SuperMix for qPCR (+ GDNA WIPER) kit instructions, reverse transcription was performed to obtain cDNA, steps were as follows:
(1) RNA template, 5× HiScript III qRT Supermix, 4× GDNA WIPER and RNase-Free ddH 2 O were dissolved and placed in ice box for use.
The reaction system was formulated as follows in table 2:
TABLE 2 reaction system
Gently beating and mixing by a pipetting gun. 42 ℃ for 2min.
(2) Directly adding 5X HiScript III qRT Supermix into the reaction tube of the first step
TABLE 3 first step reaction System
The mixture was gently beaten and mixed by a pipette, and reverse transcription was performed under the following conditions.
TABLE 4 reverse transcription procedure
3. Construction of pTRV2-AhBI-1vigs expression vector
Specific primers (pTRV 2-AhBI-1R/F and pTRV2-AhBI-1vigs R/F) are designed according to the gene sequence information, peanut cDNA is used as a template to amplify target fragments (see SEQ ID No.2 of the sequence table), the reaction system is shown in the following table 5, and the PCR reaction program is referred to 2×)Max Master Mix (Dye Plus) instruction.
TABLE 5 PCR reaction system (total volume 20. Mu.L)
The reaction procedure was as follows:
After the PCR product is detected by 1% agarose gel electrophoresis, the target gene fragment is purified and recovered by a DNA purification and recovery kit, and the concentration of the target gene fragment is measured.
Extracting pTRV2 plasmid, selecting BamHI and EcoRI enzyme cutting sites, designing specific primers, adding homologous arm sequences with proper length, and carrying out double enzyme cutting on the vector plasmid; the target fragment and the linearized pTRV2 vector are connected by homologous recombination.
E.coli DH5 alpha is transformed, and monoclonal colony is selected for bacterial liquid PCR identification to be positive.
4. GV3101 competence transformed with recombinant plasmid
Preparation of GV3101 competent cells
(1) Melting GV3101 strain stored at-80deg.C in ice box, streaking on YFP plate containing resistance (Rif: 25mg/L; str:25 mg/L), and culturing in a constant temperature incubator at 28deg.C for 2-3d to obtain single colony.
(2) Single colonies were picked and inoculated into 5mL YFP liquid medium (Rif: 25mg/L; str:25 mg/L), 28℃at 180rpm, and shake-cultured overnight.
(3) According to the following steps of 1:50 were inoculated into a new 100mL of resistant (Rif: 25mg/L; str:25 mg/L) YEP liquid medium and cultured until OD600 was 0.5.
(4) The bacterial liquid after the culture is ice-bathed for 30min, and simultaneously, reagents and materials (centrifuge tubes, EP tubes, gun heads and the like) required by competence are prepared by precooling.
(5) And (3) subpackaging the bacterial liquid into a 50mL centrifuge tube in an ultra-clean bench, centrifuging at 4 ℃/5000rpm for 10min, and discarding the supernatant.
(6) After the residual liquid was removed as much as possible, the supernatant was discarded by gentle resuspension with pre-chilled 20mM CaCl 2 (10% glycerol), centrifugation at 4℃at 5000rpm for 10min.
(6) Adding appropriate amount of 20mM CaCl 2 (containing 10% glycerol) to resuspend thallus, sub-packaging 200 μl per tube, vertically placing tweezers into liquid nitrogen for quick freezing, and preserving at-80deg.C for use.
(II) transformation of GV3101 competent cells
(1) The clone competent cells (DH 5. Alpha. Competent cell) were thawed on ice.
(2) 10. Mu.L of the recombinant product was added to 100. Mu.L of competent cells in liquid form, and the mixture was gently stirred (mixed without shaking) and allowed to stand on ice for 30min.
(3) After heat shock in a water bath at 42 ℃ for 60sec, the mixture is immediately placed on ice for cooling for 3-5min.
(4) 900. Mu.L of liquid LB medium (without antibiotics) was added and resuscitated at 37℃for 1h (rotation speed 200 rpm).
(5) At the same time, LB solid medium plates of the corresponding resistance (Kana) 100 ug/ml+rifampin (Rif) 25 ug/ml+streptomycin (Str) 25 ug/ml) were pre-heated in an incubator at 37 ℃.
(6) The bacteria were resuspended by pipetting, 100. Mu.L of the resuspended bacteria were gently spread on plates containing the correct resistance with sterile spreading bars, the plates were sealed and labeled.
(7) Culturing in an incubator at 37deg.C for 12-16 hr.
(8) Single colonies with consistent growth vigor on the transformation plate are selected for bacterial liquid PCR identification, and a reaction system for preserving positive clone bacterial liquid (50% glycerol 1:1 preservation) is shown in the following table 6.
TABLE 6 PCR reaction system (total volume 10. Mu.L)
And detecting the PCR amplification product by 1% agarose gel electrophoresis, selecting bacterial liquid with correct bands for carrying out detection, carrying out sequence comparison, and carrying out subsequent experiments with correct sequences.
Results: the positive bacterial liquid containing the target gene is successfully obtained.
Example 2 Agrobacterium-mediated pollen tube channel method for transformation of peanuts
1. Injection of
Selecting full peanut seeds (variety: zhonghua No. 2), husking, accelerating germination for 3-4d in wet perlite at the temperature of 26+/-2 ℃, peeling the seed coats after the seeds germinate, transferring the seeds into an improved Hoagland culture solution for water culture for 3-4d, wherein the culture condition is 26+/-2 ℃, illumination is 30-50 mu mol m -2s-1, and illumination period is 16h/8h, and carrying out infection work when a third true leaf appears.
Preparing fresh dyeing liquor (pTRV 1, pTRV2-AhBI-1vigs, pTRV 2-AHPDSVIGS)
(1) Culture broths (pTRV 1, pTRV2-AhBI-1vigs, pTRV 2-AHPDSVIGS): taking fresh bacterial liquid (positive after PCR) and respectively culturing (28 ℃ C., 200 rpm) in 200mL of LB liquid culture medium (containing Kana:100 mug/mL, rif:25 mug/mL, str:25 mug/mL) overnight to make OD 600 reach about 0.8-1.0;
(2) Centrifuging at 5000rpm for 10min, and collecting thalli;
(3) Washing the thalli with a small amount of LB liquid, and centrifuging again;
(4) The cells were resuspended in LB liquid medium (10 mM MES (2-morpholinoethanesulfonic acid), 10mM MgCl 2 (magnesium chloride) and 100 mM AS (acetosyringone) to an OD 600 of about 1.0.
And (3) re-suspending the bacterial liquid, and gently mixing the re-suspended bacterial liquid with PTRV1 re-suspended bacterial liquid in equal volume, and incubating for 3-5h at room temperature. The pre-cultured peanut hypodermis leaf is injected in the early morning, and the infection area is at least 75% of the leaf area. Dark culturing for 36-48h, normal light culturing, observing plant leaf phenotype change, and detecting expression of AhBI-1 by taking new leaves at the moment when yellow She Xianxiang with different degrees appears in positive comparison of about two weeks, namely constructing a peanut AhBI-1 gene silencing system.
2. Verification of Positive plants
Two weeks after injection when yellow She Xianxiang was observed in the positive control, new leaves were taken to detect AhBI-1 expression. RNA from the new leaves was extracted, reverse transcribed into cDNA, and the amount of expression of AhBI-1 was quantitatively determined by fluorescence, and qPCR (primer: qAhBI-1R/F) was mainly performed using ChamQ Universal SYBR QPCR MASTER Mix (Vazyme). The specific reaction system is shown in Table 7, and the reaction procedure is shown in Table 8.
TABLE 7 qPCR reaction system (total volume 20. Mu.L)
Table 8 qPCR reaction system (total volume 20. Mu.L)
The specific annealing temperature and the required extension time are adjusted and set by referring to the specific information of each gene. Three biological replicates were set and data processing was calculated using the 2 -ΔΔCt method.
Results: the peanut plants containing the target genes are successfully screened, the positive rate conversion rate is 62.5%, the difference of growth phenotypes is obvious, and the peanut plants can be used for subsequent research of related functions of the genes.
Sequence listing
<110> University of Guangxi
<120> Peanut AhBI-1 Gene VIGS silencing System
<160> 8
<170> SIPOSequenceListing 1.0
<210> 1
<211> 738
<212> DNA
<213> Artificial sequence (ARTIFICIAL SEQUENCE)
<400> 1
atggattctt ttacttcgtt cttcgattct tcccgaaccc gctggagcta cgatgctctc 60
aagaacttcc atcagatctc tcccgtagtt cagaatcatc tcaagcaggt ttattttacg 120
ctatgttgcg ctgtggttgc ttcagctgtt ggtgcttacc ttcatgtgct gtggaatatt 180
ggaggtctac tcactgcttt ggcttccatt ggaagctatg tgtggttgat gtccacacct 240
ccttttgaag agcaaaagag ggttactttg ttgatggttt cggccctgtt tcaaggtgcc 300
tacattggac ctcttattga tctggctatt caagttgaac caagccttat ctttactgcg 360
tttgtgggaa cttccttggc cttcgcatgt ttctcagcgg cagctttggt tgcaaagcgt 420
agggagtacc tctaccttgg cggcatgctt tcttctgggt tgtctcttct tatgtggctg 480
catttcgctt cctccatctt tggtggttcg atagcacttt ttaagtttga gttgtatttt 540
ggactcttgg tatttgtggg ttacgtgatc gtagataccc aagaaataat tgagagggca 600
cactttggtg atctagatta tgtgaagcat gccatgactc tgtttactga tttggctgca 660
atctttgtgc ggattcttgt tataatgttg aagaattcgg ttgagaaaaa tgagaaaaag 720
aacaagagga gagagtga 738
<210> 2
<211> 300
<212> DNA
<213> Artificial sequence (ARTIFICIAL SEQUENCE)
<400> 2
atggattctt ttacttcgtt cttcgattct tcccgaaccc gctggagcta cgatgctctc 60
aagaacttcc atcagatctc tcccgtagtt cagaatcatc tcaagcaggt ttattttacg 120
ctatgttgcg ctgtggttgc ttcagctgtt ggtgcttacc ttcatgtgct gtggaatatt 180
ggaggtctac tcactgcttt ggcttccatt ggaagctatg tgtggttgat gtccacacct 240
ccttttgaag agcaaaagag ggttactttg ttgatggttt cggccctgtt tcaaggtgcc 300
<210> 3
<211> 46
<212> DNA
<213> Artificial sequence (ARTIFICIAL SEQUENCE)
<400> 3
actcttgacc atggtagatc tatggattct tttacttcgt tcttcg 46
<210> 4
<211> 49
<212> DNA
<213> Artificial sequence (ARTIFICIAL SEQUENCE)
<400> 4
ggggaaattc gagctggtca cctcactctc tcctcttgtt ctttttctc 49
<210> 5
<211> 46
<212> DNA
<213> Artificial sequence (ARTIFICIAL SEQUENCE)
<400> 5
gtgagtaagg ttaccgaatt catggattct tttacttcgt tcttcg 46
<210> 6
<211> 40
<212> DNA
<213> Artificial sequence (ARTIFICIAL SEQUENCE)
<400> 6
tggaggcctt ctagagaatt cggcaccttg aaacagggcc 40
<210> 7
<211> 19
<212> DNA
<213> Artificial sequence (ARTIFICIAL SEQUENCE)
<400> 7
tggaggtcta ctcactgct 19
<210> 8
<211> 18
<212> DNA
<213> Artificial sequence (ARTIFICIAL SEQUENCE)
<400> 8
aagataaggc ttggttca 18
Claims (3)
1. The application of a gene specific fragment for silencing a peanut AhBI-1 gene in constructing a peanut dwarfing phenotype is characterized in that the gene specific fragment is AhBI-1vigs and is a base sequence of a sequence table SEQ.ID.NO. 2.
2. Use of VIGS viral vector for silencing peanut AhBI-1 gene in constructing peanut dwarf phenotype, characterized in that the VIGS viral vector is pTRV2 vector containing the gene specific fragment of claim 1, which is recombinant viral vector pTRV2-AhBI-1VIGS, constructed by ligating the gene specific fragment of claim 1 into VIGS viral backbone vector pTRV 2.
3. Use of a peanut AhBI-1 gene VIGS silencing system product in the construction of a peanut dwarf phenotype, characterized in that the silencing system product comprises a gene-specific fragment as defined in claim 1 or a VIGS viral vector as defined in claim 2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210280701.XA CN114621962B (en) | 2022-03-21 | 2022-03-21 | Peanut AhBI-1 gene VIGS silencing system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210280701.XA CN114621962B (en) | 2022-03-21 | 2022-03-21 | Peanut AhBI-1 gene VIGS silencing system |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114621962A CN114621962A (en) | 2022-06-14 |
CN114621962B true CN114621962B (en) | 2024-05-14 |
Family
ID=81903887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210280701.XA Active CN114621962B (en) | 2022-03-21 | 2022-03-21 | Peanut AhBI-1 gene VIGS silencing system |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114621962B (en) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1419541A (en) * | 2000-03-27 | 2003-05-21 | 应用研究系统Ars股份公司 | Pharmaceutically active pyrrolidine derivatives as BAX inhibitors |
DE102004024184A1 (en) * | 2004-05-13 | 2006-01-26 | Basf Plant Science Gmbh | Novel nucleic acid sequences and their use in methods for achieving pathogen resistance in plants |
BRPI0408286A (en) * | 2003-03-12 | 2006-03-07 | Basf Plant Science Gmbh | process for generating or increasing plant resistance to at least one biotic or abiotic stress factor, polypeptide sequence encoding a bi1 protein, nucleic acid sequence, recombinant expression cassette, recombinant vector and organism |
WO2011084718A1 (en) * | 2009-12-17 | 2011-07-14 | The Curators Of The University Of Missouri | Plant genes associated with seed oil content and methods of their use |
CN102660555A (en) * | 2012-05-03 | 2012-09-12 | 广西大学 | Peanut senescence gene for regulating programmed cell death, coding sequence and application |
CN102892890A (en) * | 2010-03-18 | 2013-01-23 | 巴斯夫植物科学有限公司 | Plants having enhanced yield-related traits and method for making the same |
CN102939383A (en) * | 2009-12-30 | 2013-02-20 | 先锋国际良种公司 | Methods and compositions for targeted polynucleotide modification |
CN103740753A (en) * | 2013-12-28 | 2014-04-23 | 杭州师范大学 | Application of BI-1 gene in promoting growth of catharanthus roseus cells and method |
CN111328287A (en) * | 2017-07-04 | 2020-06-23 | 库瑞瓦格股份公司 | Novel nucleic acid molecules |
CN113736819A (en) * | 2021-09-02 | 2021-12-03 | 浙江大学 | Method for constructing butterfly flower gene silencing system |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8014957B2 (en) * | 2005-12-15 | 2011-09-06 | Fred Hutchinson Cancer Research Center | Genes associated with progression and response in chronic myeloid leukemia and uses thereof |
-
2022
- 2022-03-21 CN CN202210280701.XA patent/CN114621962B/en active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1419541A (en) * | 2000-03-27 | 2003-05-21 | 应用研究系统Ars股份公司 | Pharmaceutically active pyrrolidine derivatives as BAX inhibitors |
BRPI0408286A (en) * | 2003-03-12 | 2006-03-07 | Basf Plant Science Gmbh | process for generating or increasing plant resistance to at least one biotic or abiotic stress factor, polypeptide sequence encoding a bi1 protein, nucleic acid sequence, recombinant expression cassette, recombinant vector and organism |
DE102004024184A1 (en) * | 2004-05-13 | 2006-01-26 | Basf Plant Science Gmbh | Novel nucleic acid sequences and their use in methods for achieving pathogen resistance in plants |
WO2011084718A1 (en) * | 2009-12-17 | 2011-07-14 | The Curators Of The University Of Missouri | Plant genes associated with seed oil content and methods of their use |
CN102939383A (en) * | 2009-12-30 | 2013-02-20 | 先锋国际良种公司 | Methods and compositions for targeted polynucleotide modification |
CN102892890A (en) * | 2010-03-18 | 2013-01-23 | 巴斯夫植物科学有限公司 | Plants having enhanced yield-related traits and method for making the same |
CN102660555A (en) * | 2012-05-03 | 2012-09-12 | 广西大学 | Peanut senescence gene for regulating programmed cell death, coding sequence and application |
CN103740753A (en) * | 2013-12-28 | 2014-04-23 | 杭州师范大学 | Application of BI-1 gene in promoting growth of catharanthus roseus cells and method |
CN111328287A (en) * | 2017-07-04 | 2020-06-23 | 库瑞瓦格股份公司 | Novel nucleic acid molecules |
CN113736819A (en) * | 2021-09-02 | 2021-12-03 | 浙江大学 | Method for constructing butterfly flower gene silencing system |
Non-Patent Citations (4)
Title |
---|
A novel VIGS methoed by agroinoculation of cotton seeds and application for elucidating functions of GhBI-1 in salt-stress response;Jingxia Zhang等;Plant Cell Rep;全文 * |
An efficient method for the production of transgenic peanut plants by pollen tube transformation mediated by Agrobacterium tumefaciens;Zhou Min;Plant Cell;20230327;全文 * |
Predicted:Arachis hypogaea bax inhibitor 1(LOC112802210),mRNA;NCBI;Genbank Database;Accession No.XM_025845315.2 * |
花生AhBI-1的克隆、生物信息学分析、亚细胞定位及其在铝胁迫下的表达分析;罗锦等;分子植物育种;第4页倒数第二段 * |
Also Published As
Publication number | Publication date |
---|---|
CN114621962A (en) | 2022-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020100579A4 (en) | APPLICATION OF GhPRXR1 PROTEIN AND CODING GENE THEREOF IN REGULATING AND CONTROLLING OIL CONTENT OF COTTONSEED | |
CN110183526B (en) | Protein OsPPR5 for controlling rice grain thickness and thousand grain weight and coding gene and application thereof | |
CN116444636B (en) | Rice OsGLP3-6 for inhibiting sclerotinia and application thereof | |
CN116425847B (en) | Rice OsGLP8-10 for inhibiting sclerotinia and application thereof | |
CN116355067B (en) | Rice OsGLP8-12 for inhibiting sclerotinia and application thereof | |
CN109706156B (en) | Application of RNA interference vector FveDDM1-RNAi for promoting early flowering of strawberry | |
CN110628725B (en) | Citrus yellowed vein clearing virus mutant and construction method thereof | |
CN110592100B (en) | Cassava CAMTA gene and construction and disease-resistant application of suppression expression vector thereof | |
CN114621962B (en) | Peanut AhBI-1 gene VIGS silencing system | |
CN109266643B (en) | Grape intra-berry necrosis virus infectious clone and construction method thereof | |
CN115772212A (en) | Alfalfa chloroplast MsSAP22 gene and application thereof in improving drought resistance of plants | |
CN109810998B (en) | Tomato chlorosis virus prevention and treatment method and application | |
CN109880845B (en) | Method for improving plant nodulation nitrogen fixation efficiency | |
CN108754019B (en) | Amplification method of porcine epidemic diarrhea virus ORF1 gene complete sequence | |
CN107602675B (en) | Nostoc flagelliforme Nfcuspin 1 drought-resistant gene and amino acid sequence and application thereof | |
CN117327731A (en) | Early VIGS silencing system for peanuts and construction method thereof | |
CN111471691A (en) | Application of FveCHA1 gene and RNAi vector in promoting strawberry callus formation and isolated bud regeneration | |
CN114107371B (en) | Cucumber green mottle mosaic virus gene mediated transgenic tobacco method | |
CN113584055B (en) | Pepper PNPAL3 gene and application thereof in resisting blast of peppers | |
CN112375780B (en) | Coral vegetable PDS gene VIGS silencing system and construction method and application thereof | |
CN109385448B (en) | Pumpkin mosaic virus infectious cloning vector and construction method thereof | |
CN114350675B (en) | LuNAC gene for regulating and controlling synthesis of flax secondary wall and application thereof | |
CN113136397B (en) | Recombinant vector for improving gene editing efficiency of gentiana rigescens and preparation method and application thereof | |
CN115807030B (en) | LaSCL6 protein related to defoliation time, and coding gene and application thereof | |
CN109337917B (en) | Nfdirp drought-resistant gene, coded amino acid sequence thereof and application thereof in improving plant drought resistance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |